Usted buscó: angioplastika (Esloveno - Inglés)

kpp angioplastika brez kpp angiografija brez angioplastike ali kpp
cabg angioplasty without cabg angiography without angioplasty or cabg

mi = miokardni infarkt, ptca = prekutana transluminalna koronarna angioplastika.
ami = acute myocardial infarction; cabg = coronary artery bypass graft; chd = coronary heart disease; mi = myocardial infarction; ptca = percutaneous transluminal coronary angioplasty.

angioplastika ali „ perkutana koronarna intervencija “ (pci) je kirurški postopek za odpravljanje blokad v srčnih krvnih žilah.
angioplasty or ‘ percutaneous coronary intervention’ (pci) is an operation to unblock the heart’ s blood vessels.

mednje sodijo na primer tudi vsi bolniki, pri katerih bo verjetno opravljena zgodnja ptca (perkutana transluminalna koronarna angioplastika (glejte poglavje 5. 1).
patients most likely to benefit from integrilin treatment are those at high risk of developing myocardial infarction within the first 3-4 days after onset of acute angina symptoms including for instance those that are likely to undergo an early ptca (percutaneous transluminal coronary angioplasty) (see section 5.1).

sem spadajo bolniki, pri katerih naj bi se izvedla perkutana transluminalna koronarna angioplastika (ptca, tj. vrsta kirurškega posega za čiščenje arterij, ki oskrbujejo srce).
this includes patients who are having percutaneous transluminal coronary angiography (ptca, a type of surgery to clear the arteries supplying the heart).

delež bolnikov s primarnim opazovanim dogodkom [srčno-žilna (sŽ) smrt, miokardni infarkt (mi) ali kap] je bil 582 (9,3 %) v skupini, zdravljeni s klopidogrelom, in 719 (11,4 %) v skupini, ki je prejemala placebo, to je 20 % zmanjšanje relativnega tveganja (95 % iz od 10 % - 28 %; p=0,00009) v skupini, zdravljeni s klopidogrelom (17 % zmanjšanje relativnega tveganja, če so bili bolniki zdravljeni konzervativno, 29 % kadar je bila izvedena perkutana transluminalna koronarna angioplastika (ptca) z ali brez stenta in 10 %, če je bila izvedena premostitvena operacija koronarnih arterij (cabg)).
the number of patients experiencing the primary endpoint [cardiovascular (cv) death, myocardial infarction (mi), or stroke] was 582 (9.3%) in the clopidogrel-treated group and 719 (11.4%) in the placebo-treated group, a 20% relative risk reduction (95% ci of 10%-28%; p = 0.00009) for the clopidogrel-treated group (17% relative risk reduction when patients were treated conservatively, 29% when they underwent percutaneous transluminal coronary angioplasty (ptca) with or without stent and 10% when they underwent coronary artery bypass graft (cabg).